Monday Nov 13, 2023
Monday Nov 13
8:30 am – 10:00 am
Registration
Monday Nov 13
6:30 pm
Opening
Monday Nov 13
7:00 pm
Keynote Address
Tom W. Scott (UC-Davis, US/Peru)
Monday Nov 13
8:00 pm
Welcoming Reception
Tuesday Nov 14, 2023
Tuesday Nov 14
8:30 am – 10:00 am
Epidemiology / Phylogenetics
“Insights from mathematical modelling in understanding the potential of Wolbachia to control arboviruses”
Hendrik Salje (U. of Cambridge, UK)
“Butantan dengue vaccine phase 3 results”
Mauricio Nogueira (FAMERP, Brazil)
“Chikungunya transmission during the COVID-19 pandemic: A cohort study in an urban informal settlement”
Jaqueline S. Cruz (Fiocruz-Bahia, Brazil)
“Prior Zika or dengue virus infection increases risk of subsequent symptomatic infection by dengue virus serotypes 2, 3, and 4 but not serotype 1”
José Victor Zambrana (SSI, Nicaragua)
“Oropouche virus as an emerging cause of acute febrile illness in Colombia”
Jorge Osorio (UW Madison, USA)
Tuesday Nov 14
10:00 am – 10:30 am
Coffee break
Tuesday Nov 14
10:30 am – 12:00 pm
Modeling / Public Health / Burden of Disease
“Immune landscapes of dengue virus”
Derek Cummings (U. of Florida, US)
“Global arbovirus initiative: Preparing for the next pandemic by tackling mosquito-borne viruses with epidemic and pandemic potential”
Diana Rojas (PAHO)
“Projecting the public health impact of a novel dengue vaccine using model-derived efficacy estimates”
Manar Alkuzweny (U. Notre Dame, US)
“Dengue virus lineage classification system to improve genomic surveillance”
Verity Hill (Yale, US)
“Genomic surveillance of CHIKV circulating in Argentina 2023”
Cintia Fabbri (ANLIS, Argentina)
Tuesday Nov 14
12:00 pm – 1:30 pm
Lunch
Tuesday Nov 14
1:30 pm – 3:00 pm
Vector Biology / Vector-Virus Interactions
“Dissecting mosquito vector competence to viruses”
Joao T. Marques (U. Fed. Minas Gerais, Brazil)
“Mosquito-Virus interactions and zika virus emergence”
Louis Lambrechts (Pasteur Inst., France)
“Modifications caused by the NS1 protein of the dengue virus in the intestinal epithelium of the Aedes aegypti mosquito favor virus dissemination”
Edgar Quezada (IPN, Mexico)
“H3 histone methylations patterns in the midgut of Aedes aegypti mosquitoes infected with dengue virus serotype-2”
Grecia Hernández (CISEI, Mexico)
“16S rRNA Metagenomic characterization of individual midgut microbiota of Aedes aegypti larvae from hatchery and two localities of Tumbes, Peru”
Omar Melo (UPCH, Peru)
Tuesday Nov 14
3:00 pm – 3:30 pm
Coffee break
Tuesday Nov 14
3:30 pm – 5:00 pm
Ecology / Vector Control
“Harnessing heterogeneity to guide innovative Aedes aegypti control interventions in urban areas”
Gonzalo Vasquez-Prokopec (Emory U., US/Argentina)
“Wolbachia method: results and perspectives”
Gabriel Sylvestre (WMP, Brazil)
“Rapid detection of dengue virus natural infection in Aedes aegypti from Peru by combined, portable real-time quantitative polymerase chain reaction and next generation sequencing”
Marisa Lozano (Vysnova Partners, Peru)
“The Asian tiger mosquito invasion story in forest of Central Africa and potential consequences in a One Health perspective”
Judicaël Obame-Nkoghe (DRC, Gabon)
“Exploring Aedes aegypti dynamics through Wolbachia replacement and hybrid suppress-then-replace strategies for dengue control”
Katie Tiley (CMMID, UK)
Tuesday Nov 14
5:00 pm – 5:30 pm
Coffee break
Tuesday Nov 14
5:30 pm – 6:30 pm
Round Table: Vaccines
Moderator: Albert Ko (Yale, US)
Panelists
Anna Durbin (Jonhs Hopkins, US)
Derek Wallace (Takeda, Japan)
Gabriela Paz-Bailey (CDC Dengue Branch, US)
Aravinda de Silva (UNC-Chapel Hill, US)
German Añez (Merck, US)
Tuesday Nov 14
6:30 pm – 8:00 pm
Poster Session A
Exhibition of posters for the following categories:
- Diagnostics – Prognostics – Clinical
- Immunology – Vaccines
- Vector Biology – Ecology – Control
Wednesday Nov 15, 2023
Wednesday Nov 15
8:30 am – 10:00 am
Virology
“What makes an effective live-attenuated vaccine? New insights into molecular mechanisms driving the innate cellular response to yellow fever virus 17D (YFV-17D)”
Sonja Best (NIAID/NIH, US)
“Molecular studies on the 3’UTR of the chikungunya virus genome”
Claudia Filomatori (U. de San Martin, Argentina)
“Identification of an essential RNA element located just downstream of the stop codon in the dengue virus genome”
Diego Ojeda (CONICET, Argentina)
“Constraining arboviruses to their arthropod vectors”
Gonzalo Moratorio (Inst. Pasteur, Uruguay)
“Mayaro virus pathogenesis and immunity in rhesus macaques”
Withney Weber (OHSU, US)
Wesdnesday Nov 15
10:00 am – 10:30 am
Coffee break
Wednesday Nov 15
10:30 am – 12:00 pm
Virology / Pathogenesis
“Genetic screens expose ER protein biogenesis as achilles heel for dengue virus replication”
Jan Carette (Standford U., US)
“Searching for new functions and protein-interactions of the dengue virus NS1 protein”
Juan Ludert (CINVESTAV, Mexico)
“Accumulation of Zika virus noncoding subgenomic flavivirus RNAs downregulates the translation of antiviral genes in human host”
Horacio Pallarés (IIBA-CONICET, Argentina)
“Genetic ancestry-associated differences in dengue virus infection in human skin”
Michelle Martí (U. of Pittsburgh, US)
“Co-translational proline hydroxylation is essential for flavivirus biogenesis”
Raul Andino (UCSF, US)
Wesdnesday Nov 15
12:00 pm – 1:30 pm
Lunch
Wednesday Nov 15
1:30 pm – 3:00 pm
Pathogenesis / Antivirals
“The architecture of the mature flavivirus particle impacts the neutralization breadth of cross-reactive antibodies against dengue virus”
Félix Rey (Pasteur Inst., France)
“Multidisciplinary research on neglected arboviruses at the Brazilian synchrotron source”
Rafael Marques (CNPEM, Brazil)
“Induction of a pro-inflammatory profile in human polarized macrophages following chikungunya virus infection”
Félix Delgado (U. El Bosque, Colombia)
“Spondweni virus infection in pregnant rhesus macaques causes prolonged viremia and no apparent fetal harm”
Hunter Ries (USP, Brazil)
“Monoclonal antiobody against Zika Virus E protein EDI/II domain confers protection in immunocompromised mice”
Bianca Almeida (USP, Brazil)
Wesdnesday Nov 15
3:00 pm – 3:30 pm
Coffee break
Wednesday Nov 15
3:30 pm – 5:00 pm
Clinical
“Dengue virus serotypes 2 and 3 most associated with disease severity across 17 years of a pediatric hospital-based study in Nicaragua”
Federico Narvaez (SSI, Nicaragua)
“Development of maternal neutralizing antibodies during pregnancy post Zika virus infection is associated with lower risk of microcephaly and structural brain abnormalities in exposed infants”
Karin Nielsen-Saines (UCLA, US)
“Clinical characterization and severity of patients diagnosed with dengue in different age groups during the 2019 dengue epidemic in Brazil”
Flora Gandolfi (LPV – FAMERP, Brazil)
“Dengue virus serologic prevalence and prospective cohort in adult population from metropolitan area of Medellín, Colombia 2018-2022”
Andrea Trujillo-Correa (U. de Antioquia, Colombia)
“Characteristics of dengue index cases enrolled to prospective phase 0 study of dengue infection in index cases and household contacts in Nha Trang – Vietnam”
Lisbeth Van Wesenbeeck (Janssen, Belgium)
Wesdnesday Nov 15
5:00 pm – 5:30 pm
Coffee break
Wednesday Nov 15
5:30 pm – 6:30 pm
Round Table: Arbovirus research in Peru
“Situación del Dengue enel Perú”
Cesar Munayco Escate (CDC-MoH. Peru)
“Diagnóstico y Vigilancia de serotipos y genotipos en el Perú, 1990-2023”
Oscar Escalante (INS-MoH, Peru)
“Comparison of in silico predicted linear B-cell epitopes for dengue virus with epitopes discovered in a proteome-wide peptide microarray analysis”
Francesca Falconi-Agapito (UPCH, Peru)
“Knowledge, attitudes, and practices regarding dengue and malaria in remote communities of the Peruvian Amazon”
Rosa Angelina Rodriguez-Vasquez (PRISMA, Peru)
“Targeted Indoor Residual Spray (TIRS) for Aedes aegypti with novel chemical compounds”
Helvio Astete (NAMRU-6, Peru)
Wednesday Nov 15
6:30 pm – 8:00 pm
Poster Session B
Exhibition of posters for the following categories:
- Epidemiology – Genomics – Phylogenetics – Modelling – Burden of Disease
- Virology – Pathogenesis – Antivirals
- Human Behavior & Community Engagement
Thursday Nov 16, 2023
Thursday Nov 16
8:30 am – 10:00 am
Immunology
“Molecular mechanisms underlying flavivirus-dendritic cell interactions”
Sujan Shresta (La Jolla Inst. for Immunology, US)
“Multi-Tissue transcriptomic study in severe dengue disease: In silico analysis of potential drugs for its management”
Beatriz Sierra (IPK, Cuba)
“Dengue virus NS5 modulates pro-inflammatory cytokine production in a serotype–specific manner”
María Gonzalez (CONICET, Argentina)
“Antibody correlates of severe disease in secondary dengue virus infection after a primary Zika virus infection: A possible role for IgA”
Jaime Cardona-Ospina (UC Berkeley, US)
“Depletion of CD8+ T cells reveals CD4+ T cell contribution in controlling zika viremia in dengue-immune Mmacaques”
Crisanta Serrano-Collazo (UPR, Puerto Rico)
Thursday Nov 16
10:00 pm – 10:30 pm
Coffee break
Thursday Nov 16
10:30 am – 12:00 pm
Immunology/Vaccines
“Immunity to dengue virus”
David Martinez (Yale U., US)
“What we have learned about protective immunity from dengue controlled human infection and live attenuated vaccine studies”
Anna Durbin (Johns Hopkins, US)
“Efficacy and safety of Takeda’s tetravalent dengue vaccine candidate (TAK-003) after 4.5 years of follow-up”
Vianney Tricou (Takeda, Switzerland)
“Tumor Necrosis Factor (TNF) contributes to joint inflammation, hypernociception and disease severity in chikungunya virus infection: Implications for therapeutic interventions”
Vivian Costa (U. Fed. Minas Gerais, Brazil)
“Development of a powassan virus like particle vaccine adjuvanted with novel toll-like receptor agonists”
Michael Crawford (OHSU, US)
Thursday Nov 16
12:00 pm – 1:30 pm
Lunch
Thursday Nov 16
1:30 pm – 3:00 pm
Diagnostics / Severity Markers / Prognostics
“Multiplex sample-sparing antibody assay platform for arbovirus surveillance and diagnostics”
Prem Lakshmanane (UNC Chapel Hill, US)
“Evaluation of commercial anti-dengue virus IgG test performance to facilitate dengue immunization”
Freddy Medina (CDC, Puerto Rico)
“Development of chimeric Zika virus proteins for serological diagnosis of low cross-reactivity”
Samille Pereira (U. Fed. Minas Gerais, Brazil)
“The serum metabolome reveals insights into dengue virus infection and disease severity”
Paul Soma (Colorado State U., US)
“When computer science met virology: Methodologies for quantitative antigen testing of the four serotypes of dengue virus”
Irene Bosch (MIT, US)
Thursday Nov 16
3:00 pm – 3:30 pm
Coffee break
Thursday Nov 16
3:30 pm – 5:00 pm
Human Behavior & Community Engagement
“Participatory research in Nicaragua: data and community mobilization in the control of aedes aegypti”
Harold Suazo (SSI, Nicaragua)
“Characterization of human mobility to improve dengue prevention strategies”
Veerle Vanlerberghe (Inst. of Tropical Med., Belgium)
“Estrategias educativas y comunicativas para el control del dengue en dos poblaciones con alta carga de la enfermedad: Un enfoque en educación en salud”
Santiago Morales-Mesa (U. CES, Colombia)
“Efectividad de la Estrategia Municipal para el Control Integral del Dengue en Xochitepec, Morelos, México”
Hilda Rangel (INS, Mexico)
“Dengvaxia® vaccine acceptability and identification of reasons for vaccine hesitancy among parents from a community cohort in Ponce, Puerto Rico”
Dania Rodriguez (CDC, Puerto Rico)
Thursday Nov 16
5:00 pm – 5:30 pm
Coffee break
Thursday Nov 16
5:30 pm – 6:30 pm
Round Table: Vector control intervention
Moderator: Amy Morrison (UC-Davis, US/Peru)
Panelists:
Tom Scott (UC-Davis, US/Peru)
Gonzalo Vasquez-Prokopec (Emory U., US/Argentina)
Mauro M. Teixeira (Brazil)
Gabriela Paz-Bailey (CDC, Puerto Rico)
Josefina Coloma (UCB, US)
Thursday Nov 16
6:30 pm – 8:00 pm
